Una Health

What Una Health does

Una Health is an independent UK-based medical diagnostics distributor founded in 2009 and headquartered in Stoke-on-Trent. The company distributes point-of-care testing devices and laboratory diagnostic products from multiple international manufacturers—including Aidian (QuikRead go platform), Roche Diagnostics, Fortress Diagnostics, TECHLAB, Fujirebio, Beright, and Forte Medical—to NHS hospitals, pathology laboratories, GP surgeries, Primary Care Networks, and community care providers across the United Kingdom. Its core technology offerings center on the QuikRead go Instrument and QuikRead go Plus Instrument, portable automated analyzers running reagent kits for CRP, HbA1c, iFOBT, Strep A, and wrCRP+Hb testing, complemented by distributed products such as the Urisys 1100 urine analyser, Fortress TPHA syphilis tests, microINR anticoagulation monitoring, and the Peezy Midstream urine collection device.

The business model is B2B distribution of hardware and consumables with quote-based pricing, standard 30-day payment terms, and dedicated account management for healthcare organizations. Revenue is generated through unit sales of diagnostic instruments and recurring reagent/test kit purchases, with additional value-added services including a CPD-accredited e-learning platform supporting UKAS compliance for near-patient testing programmes. The company operates through multiple distribution channels: direct sales to NHS providers, NHS procurement framework participation, GP surgery and Primary Care Network sales, and a separate consumer OTC channel via Una Health Consumer and Una+ sub-brands. Una Health is confirmed as an SME with annual turnover below £36 million, operating with 11-50 employees, and is led by Managing Director Fiona Jacobs as the primary executive.

Name

Una Health

Legal name

Una Health Ltd

Website

https://unahealth.co.uk

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Una Health is an independent UK distributor of point-of-care and laboratory diagnostic products, serving NHS hospitals, GP surgeries, Primary Care Networks, and community care providers with distributed brands including Aidian QuikRead go, Roche, and Fortress Diagnostics since 2009.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Distribution

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

akta.pro secondary industry

Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)

Keywords

• Point-of-care diagnostics
• Medical diagnostic distribution
• Clinical laboratory products
• Infectious disease testing
• Rapid diagnostic tests

Headquarters

HQ city

Stoke-on-trent

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Diagnostic Product Distribution: Revenue generated through distribution of point-of-care testing devices, reagent kits, and diagnostic consumables to healthcare providers including NHS hospitals, GP surgeries, and community care settings across the UK.
2. Product Sales - Direct: Direct sales of diagnostic products including QuikRead go instruments, test kits, and related consumables with standard delivery charges and 30-day payment terms.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Una Health is a UK-based independent distributor of point-of-care and laboratory diagnostic products, supplying devices and reagent kits from international brands such as Aidian (QuikRead go), Roche, Fortress Diagnostics, TECHLAB, and Forte Medical to NHS hospitals, GP surgeries, Primary Care Networks, pathology laboratories, and community care providers. The portfolio covers CRP, HbA1c, iFOBT, Strep A, COVID-19, syphilis, parasite detection, urinalysis, and anticoagulation testing, complemented by a CPD-accredited e-learning platform for UKAS compliance training and a consumer OTC test sub-brand.

Product overview

Una Health is a leading UK distributor of diagnostics for laboratory and point-of-care settings, founded in 2009. The company operates as a portfolio of distributed diagnostic products rather than a single unified platform. The core product offerings include the QuikRead go Instrument and QuikRead go Plus Instrument — portable, automated point-of-care analysers that run multiple reagent tests including easy CRP, HbA1c, iFOBT, Strep A, and wrCRP+Hb. These are supplemented by distributed products from partner brands including Roche (Urisys 1100 urine analyser, Combur test strips), Fortress Diagnostics (TPHA syphilis test, RPR, COVID-19 rapid antibody and ELISA tests), Beright (COVID-19/Influenza/RSV combo test), TECHLAB (parasite detection kits), Lepzi (PLGF test for pre-eclampsia), Peezy (midstream urine collection devices), and ImmuView (automated readers). Additional offerings include microINR for anticoagulation monitoring, GlucoBooster Sport energy products, and consumer OTC tests via Una Health Consumer brand. Services include an E-Learning portal for training and UKAS compliance support.

Differentiator

Problem solved

Functional benefit

Brands

• QuikRead go: Portable point-of-care analyser for CRP, HbA1c, FIT, Strep A testing
• microINR
• Fortress Diagnostics
• TECHLAB
• Lepzi
• Peezy Midstream
• GlucoBooster Sport
• ImmuView
• Urisys 1100

Products and services

• QuikRead go Instrument Compact, fully automatic, portable point-of-care analyser that allows for quantitative and qualitative results with minimal hands-on time. Supports multiple tests including CRP, HbA1c, FIT, and Strep A for healthcare providers in community and primary care settings.
• QuikRead go Plus Instrument Enhanced portable, fully automated point-of-care testing device with touchscreen interface, 24-language support, and LIS/HIS connectivity via LAN or Wi-Fi (LIS01-A2 and POCT1-A2 compliant) for rapid and reliable analysis in clinical settings.
• QuikRead go easy CRP Easy-to-use point-of-care test providing quantitative C-reactive protein results within 2 minutes from a finger-prick blood sample, with measuring range between 1-200 mg/l, intended for antimicrobial stewardship decision support in primary care.
• QuikRead go HbA1c Point-of-care test for quantitative measurement of glycated haemoglobin (HbA1c) from finger prick capillary blood or anticoagulated venous whole blood sample, with measuring range 20-140 mmol/mol (IFCC and NGSP certified), results in 6 minutes with 1 microlitre sample for diabetes management.
• QuikRead go iFOBT Immunochemical faecal occult blood test designed to detect and measure human haemoglobin in faeces for identifying potential lower gastrointestinal bleeding, with measuring range 10-200 microgram Hb/g and LIS/HIS connectivity for colorectal cancer screening pathways.
• QuikRead go Strep A Rapid test for detection of Group A Streptococcus antigen from throat swab samples with 83% sensitivity and 97% specificity, providing results in 4 minutes for point-of-care diagnosis of streptococcal pharyngitis.
• QuikRead go wrCRP+Hb Wide range CRP and haemoglobin test providing results for hsCRP (0.5-200 mg/l) and Hb (50-220 g/l) from whole blood, serum, or plasma samples for combined inflammation and anaemia screening.
• microINR System Point-of-care system for oral anticoagulation therapy monitoring, intended for patient self-testing use as well as for healthcare professionals at point-of-care settings in cardiovascular management.
• Urisys 1100 Urine Analyser Semi-automated urine testing device from Roche, one of the smallest and lightest on the market, designed for smaller labs, doctor offices and decentralised lab settings to eliminate potential errors caused by visual comparison and interpretation in urinalysis workflows.
• Fortress Diagnostics TPHA Syphilis Test Sensitive and specific indirect haemagglutination test from Fortress Diagnostics for detection of antibodies to Treponema pallidum, requiring no specialist equipment and providing results in 45 minutes for syphilis screening and diagnosis.
• Fortress Diagnostics COVID-19 Rapid Antibody Test Single use lateral flow device for qualitative detection of total antibodies against SARS-CoV-2, CE marked and MHRA registered. Used in the Imperial College-led REACT-2 COVID-19 surveillance programme.
• Fortress Diagnostics COVID-19 ELISA Antibody Test Gold standard ELISA test from Fortress Diagnostics for detection and quantification of total antibodies providing rapid and consistent results, NHS validated testing option compatible with major ELISA platforms.
• Beright COVID-19/Influenza A+B/RSV Antigen Combo Rapid Test Rapid chromatographic immunoassay for qualitative detection of COVID-19, Influenza A, Influenza B and RSV antigens from nasopharyngeal swab samples, CTDA approved, providing 4-in-1 respiratory virus results in 15 minutes for winter respiratory testing pathways.
• Peezy Midstream Patented single-use urine collection device from Forte Medical that automatically diverts first and last portions of urine flow to capture only true midstream sample, reducing contamination rates to 0-2.5% for UTI and prenatal testing in women's health and primary care.
• ImmuView Reader 2.0 Compact automated instrument for reading and result interpretation of C. DIFF QUIK CHEK COMPLETE and related immunochromatographic assays, featuring touchscreen, barcode scanner, and LIS/LIMS connectivity via Ethernet for hospital laboratories.
• TECHLAB Parasite Detection Kits Enzyme immunoassay (EIA) based kits from TECHLAB Inc. for detection of Cryptosporidium, Giardia, and Entamoeba histolytica antigens in faecal samples, including TRI COMBO and QUIK CHEK variants, providing improved sensitivity over microscopy methods for hospital pathology laboratories.
• Lepzi Quanti PLGF Test Point-of-care test for placental growth factor (PlGF) used in pre-eclampsia testing, supporting rapid diagnosis and risk stratification in maternity and women's health settings.
• Fortress Diagnostics RPR (Rapid Plasma Reagin) Test from Fortress Diagnostics for detection of non-treponemal antibodies used in syphilis screening, diagnosis, and treatment monitoring in sexual health and laboratory settings.
• Roche Combur Test Strips 10 Parameter 10-parameter urine test strips from Roche for comprehensive urinalysis testing, used in conjunction with the Urisys 1100 analyser or visual reading in primary care and laboratory urinalysis workflows.
• GlucoBooster Sport Ready-to-use energy gel containing rapidly available glucose enriched with Vitamin C, Magnesium and Sodium, caffeine-free and vegan, in convenient single-use sachets for sports performance and elite athletics recovery.
• Una Health E-Learning Portal Online training platform providing CPD accredited training for users of diagnostic equipment, helping reduce training burden and maintain UKAS point-of-care testing compliance for healthcare professionals and organizations.

Quantifiable outcome

• 17.5% decrease in first-line antibiotic prescribing for lower respiratory tract infections with CRP point-of-care testing (South Powys pilot)
• +5 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature8 records

Partnerships

Nine partnerships are on record, tiered core, flagship and minor.

• Aidian (QuikRead go)coreChannel Partner/ Reseller/ DistributorUna Health is the UK distributor for Aidian's QuikRead go point-of-care testing platform, including instruments and reagent kits for CRP, HbA1c, iFOBT, Strep A, and other tests.
• Roche DiagnosticscoreChannel Partner/ Reseller/ DistributorUK distributor for Roche diagnostic products including Urisys urine analysers and Combur test strips for urinalysis testing.
• Fortress DiagnosticscoreChannel Partner/ Reseller/ DistributorUK distributor for Fortress Diagnostics products including TPHA syphilis tests, COVID-19 antibody and antigen tests, ELISA kits, and rapid test devices. Fortress Diagnostics is a Northern Ireland-based manufacturer.
• TECHLAB Inc.coreChannel Partner/ Reseller/ DistributorUK distributor for TECHLAB parasite detection kits including TRI COMBO and QUIK CHEK products for Cryptosporidium, Giardia, and E. histolytica detection.
• Imperial College London & Department of Health & Social CareflagshipStrategic or Co-development PartnerUna Health and Fortress Diagnostics partnered with DHSC for the REACT (Real Time Assessment of Community Transmission) study led by Imperial College London and Ipsos MORI, providing Fortress COVID-19 Total Antibody Devices for national COVID-19 surveillance.
• BerightminorChannel Partner/ Reseller/ DistributorUK distributor for Beright COVID-19/Influenza A+B/RSV Antigen Combo Rapid Test, providing 4-in-1 respiratory virus testing capability.
• Forte Medical (Peezy)coreChannel Partner/ Reseller/ DistributorUK distributor for Forte Medical's Peezy Midstream urine collection device, a patented device for reducing urine sample contamination in UTI and prenatal testing.
• FujirebiominorChannel Partner/ Reseller/ DistributorUK distributor for Fujirebio products including Serodia TPPA syphilis tests.
• ImmuView (Serralia)minorChannel Partner/ Reseller/ DistributorUK distributor for ImmuView products including C. DIFF QUIK CHEK COMPLETE and ImmuView Reader 2.0 for automated result interpretation.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Surescreen Diagnostics: UK-based developer and distributor of rapid point-of-care tests including infectious disease, pregnancy, and drug screening. Comparable B2B model selling lateral flow and rapid tests into NHS primary care and occupational health.
• Alpha Laboratories: UK-based independent distributor of diagnostic and laboratory products serving NHS hospitals, pathology labs, and research institutions. Highly comparable B2B distribution model with a similar customer base and product portfolio spanning POCT, clinical chemistry, and immunology.
• EKF Diagnostics: UK-headquartered point-of-care diagnostics company with products in HbA1c (QuikRead-style readers), haemoglobin, and infectious disease testing. Comparable product focus on connected POC devices sold through UK and international channels.
• Abingdon Health: UK-based lateral flow and rapid diagnostics developer and contract manufacturer serving clinical and OTC markets. Comparable UK diagnostics focus, though Abingdon is more on the manufacturing side while Una Health is more distribution-led.
• R-Biopharm: German diagnostics manufacturer and UK distributor with strong focus on clinical chemistry, infectious disease, and food/feed testing. Comparable product mix in faecal parasitology (TECHLAB-style assays) and POCT reagent supply.
• Calibre Scientific: Global acquirer and operator of life science and diagnostic distributors with active UK presence. Directly comparable as a roll-up of niche diagnostics distributors and a potential strategic acquirer of Una Health.

Broad incumbents

• Bio-Rad Laboratories: Global life science and clinical diagnostics company with significant UK presence distributing POC and laboratory diagnostics to NHS and private labs. Overlaps with Una Health's laboratory diagnostics and immunology distribution categories.
• Henry Schein (UK): UK arm of the global Henry Schein medical and dental supplies distributor serving NHS, dental, and primary care customers. Overlaps in POCT and medical consumables distribution but at much larger scale and broader portfolio.

Regional players

• BHR Pharmaceuticals: UK pharmaceutical and medical device distributor serving NHS hospitals and community pharmacies. Comparable UK-only B2B distribution of medical products with similar customer base, though broader into pharmaceuticals.

Others

• Roche Diagnostics UK: Global diagnostic major that is both Una Health's partner (Urisys 1100, Combur strips) and a potential competitive threat via direct UK sales. Represents the strategic principal-counterparty dynamic central to Una Health's risk profile.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/unahealth
• LinkedInlinkedin.com/company/una-health

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Una Health